Antibodies
Macromolecule in Homo sapiens that 1 drug acts on.
- Drugs that act on it: 1
- Approved: 1
- In phases 1 to 3: 0
- Sponsors: 1
Who is on it, and how far along
Every drug ChEMBL records acting on this target, by the furthest stage it has reached for any use, coloured by modality.
How to read this
Each mark is one drug. Columns run from approved to phase 1; hover or tap a mark for its sponsor, modality and open trials, and click it to open the drug.
- Protein or peptide 1
| Drug | Furthest stage | Sponsor | Modality | Action | Open trials |
|---|---|---|---|---|---|
| Imlifidase | Approved | Hansa Biopharma AB | Protein or peptide | Hydrolytic enzymeAntibodies hydrolytic enzyme | 5 |
| Imlifidase for Highly Sensitized Kidney Transplant Recipients With a posItive crossmAtch Against a Deceased Donor: Results of Kidney Transplantations Performed in Accordance to the French Guidelines. | Imlifidase | — | Not yet recruiting | University Hospital, Bordeaux | Feb 2, 2026 |
| Efficacy and Safety of GNT0003 Following Imlifidase Pre-treatment in Severe Crigler-Najjar Syndrome | Imlifidase | Phase 2 | Recruiting | Genethon | Jul 24, 2024 |
| A Long-term Follow-up Trial of Patients Previously Treated With Imlifidase Prior to Kidney Transplantation and a Non-comparative Transplanted Patient Group | Imlifidase | Phase 3 | Active, not recruiting | Hansa Biopharma AB | Jul 10, 2023 |
| Imlifidase Prior to Kidney Transplant in Highly Sensitised Children | Imlifidase | Phase 2 | Recruiting | Hansa Biopharma AB | Mar 3, 2023 |
| Survival and Dialysis Independency in Highly Sensitized Patients After Desensitization With Imlifidase and Tx of Kidneys | Imlifidase | — | Active, not recruiting | Hansa Biopharma AB | Feb 6, 2023 |
Drugs, mechanisms, furthest stage (max phase) and modality (molecule type) are from ChEMBL CHEMBL4630661, ChEMBL 37, fetched 2026-11-18 (CC BY-SA 3.0). Sponsors are the US application holder (Drugs@FDA) for approved drugs with a US page, else the industry lead sponsor of the most of the drug's ClinicalTrials.gov trials. Open trials are recruiting or ongoing studies naming the drug as an intervention on ClinicalTrials.gov, checked daily; this page as of 2026-11-22. ChEMBL and Open Targets